Diversified Consumer Services
Company Overview of University of Georgia
University of Georgia is an education institution, which offers baccalaureate, masters, doctoral, and professional degrees. It focuses on fields such as arts, humanities, social sciences, biological sciences, physical sciences, agricultural and environmental sciences, business, environmental design, family and consumer sciences, forest resources, journalism and mass communication, education, law, pharmacy, social work, and veterinary medicine. The schools and colleges of the university includes College of Agricultural and Environmental Sciences; Franklin College of Arts and Sciences; Terry College of Business; College of Education; College of Environment and Design; College of Family and Con...
Athens, GA 30602
Founded in 1785
Key Executives for University of Georgia
Senior Vice President for Finance and Administration
Senior Vice President for Academic Affairs and Provost
Vice President for Instruction
Senior Vice President for External Affairs
Compensation as of Fiscal Year 2015.
University of Georgia Key Developments
University of Georgia to Collaborate with GeoVax Labs, Inc. on Zika Vaccine
Feb 3 16
The University of Georgia announced that it has entered into a collaborative research agreement with GeoVax Labs Inc. to develop and test a vaccine to prevent the emerging and virulent Zika virus infection. The collaboration will combine the vaccine development expertise of UGA researchers led by Ted Ross, director of UGA's Center for Vaccines and Immunology, with GeoVax's novel vaccine platform technology. Ross, a professor and Georgia Research Alliance Eminent Scholar in Infectious Diseases in the College of Veterinary Medicine, joined UGA last fall. The World Health Organization on declared Zika virus an international health emergency, noting that Zika is spreading explosively and could affect as many as 4 million people in the Americas by the end of the year. The mosquito-transmitted virus is linked with birth defects in thousands of babies in Brazil, and more recently, with Guillain-Barre syndrome, a disorder in which the body's immune system attacks the nervous system. The virus is anticipated to spread to countries throughout the Western Hemisphere, with the exception of Canada and Chile. There is no proven vaccine or treatment for Zika, which is closely related to yellow fever, dengue and chikungunya viruses, also transmitted to people by mosquitoes. VLPs--virus-like particles--mimic a live virus but do not contain genetic material; they cannot replicate or cause infection, yet they elicit a strong immune response in the cells of the person being vaccinated. Vaccines using VLPs on the market are used to prevent hepatitis and Papilloma virus infections, and others are in development. GeoVax's novel vaccine platform technology takes a different approach with VLPs. Instead of introducing VLPs in the vaccine, it uses recombinant DNA or recombinant viruses to produce VLPs in the person being vaccinated so that they more closely resemble the virus generated in a person's body during a natural infection. The company's MVA-VLP platform is focused on vaccines against HIV and hemorrhagic fever viruses, including Ebola, Marburg and Lassa. The HIV vaccine has been proven safe in human clinical trials involving over 500 individuals. It also is being evaluated for use in cancer vaccines. In addition to Ross, UGA researchers working on the Zika vaccine include Ralph Tripp, Georgia Research Alliance Chair in Vaccine and Therapeutic Development; Biao He, Georgia Research Alliance Distinguished Investigator and Fred C. Davison Distinguished University Chair in Veterinary Medicine; and Mark Tompkins, associate professor of infectious diseases.
The University of Georgia Appoints Timothy Burg as Director
Jan 19 16
The University of Georgia has appointed Timothy Burg, an engineer whose work bridges academia and industry, to direct its Office of Science, Technology, Engineering and Mathematics Education. Burg, previously a professor of electrical and computer engineering at Kansas State University, will lead efforts to enhance instruction and learning outcomes in the STEM fields at UGA as well as throughout the state, with partners in K-12 education and at other universities.
Georgia Power Collaborates with University of Georgia for New Solar Project in Athens, Georgia
Dec 21 15
Georgia Power has collaborated with University of Georgia, or UGA, for a new 1MW solar tracking demonstration project in Athens, Georgia. The new project is located on a 10-acre site owned by UGA and is the result of a utility/university collaboration to further demonstrate and advance solar energy in Georgia. Research will be conducted under a two-year collaboration with UGA researchers, spearheaded by the College of Engineering, to study solar forecasting and the effects of solar panel soiling versus performance. Data analysis and performance reporting will occur through a Georgia Power partnership with the Electric Power Research Institute (EPRI). The new solar project will demonstrate optimal orientation and tracking technology suited for Georgia's climate and energy demand with project partners studying the performance and reliability of various fixed and tracking configurations of five separate sub-arrays. Georgia Power owns and will operate the facility under a 20-year lease agreement with UGA. Energy produced by the facility will flow to the state's electric grid to serve customers. UGA will receive the renewable energy credits, or RECs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|